Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Raj

Showing results (281-290 of 306) with videos related to

Pageof 31
Sort By:
Cell Reports|January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate CancerXiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
JCI Insight|July 26, 2022
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibitionSm N Udden, Qian Wang, Sunil Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Cancer Research|August 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast CancerKristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, et al.
Molecular Cancer Therapeutics|May 31, 2019
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast CancerSuryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, et al.
Cell Chemical Biology|December 30, 2019
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung CancerPaul Yenerall, Amit K Das, Shan Wang, et al.
European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.
Pageof 31

Showing results (281-290 of 306) with videos related to

Sort By:
Pageof 31
Cell Reports|January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate CancerXiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
JCI Insight|July 26, 2022
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibitionSm N Udden, Qian Wang, Sunil Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Cancer Research|August 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast CancerKristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, et al.
Molecular Cancer Therapeutics|May 31, 2019
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast CancerSuryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, et al.
Cell Chemical Biology|December 30, 2019
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung CancerPaul Yenerall, Amit K Das, Shan Wang, et al.
European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.
Pageof 31